These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10465087)

  • 1. Reversible zidovudine-induced pure red cell aplasia.
    Blanche P; Silberman B; Barreto L; Gombert B; Sicard D
    AIDS; 1999 Aug; 13(12):1586-7. PubMed ID: 10465087
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe anoxic hepatic necrosis in an HIV-1-hepatitis C virus-co-infected patient starting antiretroviral triple combination therapy.
    Karras A; Rabian C; Zylberberg H; Hermine O; Duchatelle V; Durand F; Valla D; Viard JP
    AIDS; 1998 May; 12(7):827-9. PubMed ID: 9619823
    [No Abstract]   [Full Text] [Related]  

  • 3. Pure red cell aplasia induced by lamivudine without the influence of zidovudine in a patient infected with human immunodeficiency virus.
    Nakamura K; Tateyama M; Tasato D; Haranaga S; Tamayose M; Yara S; Higa F; Fujita J
    Intern Med; 2014; 53(15):1705-8. PubMed ID: 25088890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zidovudine-induced pure red cell aplasia presenting after 4 years of therapy.
    Weinkove R; Rangarajan S; van der Walt J; Kulasegaram R
    AIDS; 2005 Nov; 19(17):2046-7. PubMed ID: 16260917
    [No Abstract]   [Full Text] [Related]  

  • 5. Precipitous declines in hemoglobin levels associated with combination zidovudine and lamivudine therapy.
    Tseng A; Conly J; Fletcher D; Keystone D; Salit I; Walmsley S
    Clin Infect Dis; 1998 Oct; 27(4):908-9. PubMed ID: 9798060
    [No Abstract]   [Full Text] [Related]  

  • 6. [Erythroblastopenia secondary to zidovudine].
    Bani-Sadr F; Hoff J; Raffi F
    Rev Med Interne; 1998 Jul; 19(7):518-9. PubMed ID: 9775204
    [No Abstract]   [Full Text] [Related]  

  • 7. Zidovudine induced pure red cell aplasia: a case report.
    Hassan A; Babadoko AA; Mamman AI; Ahmed SA
    Niger J Med; 2009; 18(3):332-3. PubMed ID: 20120657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible zidovudine-induced pure red-cell aplasia.
    Cohen H; Williams I; Matthey F; Miller RF; Machin SJ; Weller IV
    AIDS; 1989 Mar; 3(3):177-8. PubMed ID: 2496734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukocytopenia due to zidovudine- and nevirapine-containing regimens in elderly patients with HIV infection.
    Yamamoto Y; Yasuoka A; Yasuoka C; Genka I; Teruya K; Kikuchi Y; Tachikawa N; Oka S
    Jpn J Infect Dis; 2000 Dec; 53(6):244-5. PubMed ID: 11227023
    [No Abstract]   [Full Text] [Related]  

  • 10. Concern at cheap AIDS drug fears.
    Cherry M
    Nature; 1999 Nov; 402(6760):332. PubMed ID: 10586854
    [No Abstract]   [Full Text] [Related]  

  • 11. Skeletal myopathy associated with nucleoside reverse transcriptase inhibitor therapy: potential benefit of coenzyme Q10 therapy.
    Rosenfeldt FL; Mijch A; McCrystal G; Sweeney C; Pepe S; Nicholls M; Dennett X
    Int J STD AIDS; 2005 Dec; 16(12):827-9. PubMed ID: 16336769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High incidence of zidovudine induced anaemia in HIV infected patients in eastern India.
    Agarwal D; Chakravarty J; Chaube L; Rai M; Agrawal NR; Sundar S
    Indian J Med Res; 2010 Oct; 132():386-9. PubMed ID: 20966515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Panel will seek 'appropriate' AIDS goals for South Africa.
    Cherry M
    Nature; 2000 Mar; 404(6774):115. PubMed ID: 10724138
    [No Abstract]   [Full Text] [Related]  

  • 14. Tolerability of postexposure prophylaxis with zidovudine, lamivudine, and nelfinavir for human immunodeficiency virus infection.
    Rabaud C; Bevilacqua S; Beguinot I; Dorvaux V; Schuhmacher H; May T; Canton P
    Clin Infect Dis; 2001 May; 32(10):1494-5. PubMed ID: 11317252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of ritonavir and saquinavir in combination with zidovudine and lamivudine.
    Michelet C; Bellissant E; Ruffault A; Arvieux C; Delfraissy JF; Raffi F; Bazin C; Renard I; Sébille V; Chauvin JP; Dohin E; Cartier F
    Clin Pharmacol Ther; 1999 Jun; 65(6):661-71. PubMed ID: 10391672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipodystrophy body-shape changes in a patient undergoing zidovudine monotherapy.
    García-Benayas T; Blanco F; Gómez-Viera JM; Barrios A; Soriano V; González-Lahoz J
    AIDS; 2002 May; 16(7):1087-9. PubMed ID: 11953483
    [No Abstract]   [Full Text] [Related]  

  • 17. Trizivir on the market.
    Kerr C
    Trends Microbiol; 2001 Jan; 9(1):13. PubMed ID: 11166234
    [No Abstract]   [Full Text] [Related]  

  • 18. Is peripartum zidovudine 'safe and highly beneficial to African children?'.
    Crowe DR
    AIDS; 2001 Nov; 15(16):2204-5. PubMed ID: 11684947
    [No Abstract]   [Full Text] [Related]  

  • 19. Triple nuke therapy--results after one year.
    TreatmentUpdate; 2001; 12(10):3-4. PubMed ID: 11570063
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antiretroviral therapy. NNRTI (non-nucleoside reverse transcriptase inhibitor)].
    MMW Fortschr Med; 2000 Mar; 142 Suppl 1():14-6. PubMed ID: 10863304
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.